Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Facilitate connections between healthcare entities such as hospitals, clinics, health plans, and life sciences with app developers and health data partners to create innovative digital services based on FHIR APIs. Enhance both the efficiency and safety of transitions throughout the continuum of care, whether in-patient or out-patient. Offer personalized wellness and prevention strategies tailored to at-risk individuals, fostering proactive health management. Encourage collaboration among patients, healthcare providers, and physicians to effectively address chronic conditions, leading to better management outcomes. Focus on patient-centered digital services that prioritize user experience and safety, while minimizing risks during care transitions. Utilize an enterprise-grade platform capable of managing, securing, and scaling APIs that remain agnostic to FHIR servers. Seamlessly integrate healthcare data from various sources, including internal systems, external partners, or open-source FHIR-ready resources. By swiftly launching digital services like mobile applications, advance the vision of patient-centric healthcare and enhance data interoperability, ultimately improving healthcare delivery for all. This approach not only enhances patient engagement but also drives innovation across the healthcare landscape.
Description
By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.
API Access
Has API
API Access
Has API
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Founded
1998
Country
United States
Website
cloud.google.com/solutions/apigee-health-apix
Vendor Details
Company Name
PerkinElmer
Founded
1937
Country
United States
Website
perkinelmerinformatics.com/products/clinical-translational/signals-translational/